Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan D Cooper

Showing results (21-30 of 144) with videos related to

Pageof 15
Sort By:
Neurobiology of Disease|July 12, 2005
Thalamocortical neuron loss and localized astrocytosis in the Cln3Deltaex7/8 knock-in mouse model of Batten diseaseCharlie C Pontikis, Susan L Cotman, Marcy E MacDonald, et al.
Neurobiology of Disease|May 10, 2012
Selective spatiotemporal patterns of glial activation and neuron loss in the sensory thalamocortical pathways of neuronal ceroid lipofuscinosis 8 miceMervi Kuronen, Anna-Elina Lehesjoki, Anu Jalanko, et al.
Journal of Child Neurology|September 10, 2013
Regional brain atrophy in mouse models of neuronal ceroid lipofuscinosis: a new rostrocaudal perspectiveThomas G Kühl, Sybille Dihanich, Andrew M S Wong, et al.
Acta Neuropathologica|October 10, 2007
Immune system irregularities in lysosomal storage disordersJulian A Castaneda, Ming J Lim, Jonathan D Cooper, et al.
Journal of Neuropathology and Experimental Neurology|December 14, 2011
Early microglial activation precedes neuronal loss in the brain of the Cstb-/- mouse model of progressive myoclonus epilepsy, EPM1Saara Tegelberg, Outi Kopra, Tarja Joensuu, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 13, 2025
Immunostaining Methods for Lysosomal Storage Disorder ResearchEwa A Ziółkowska, Sophie H Wang, Hemanth R Nelvagal, et al.
Biochemical Society Transactions|December 2, 2010
Current therapies for the soluble lysosomal forms of neuronal ceroid lipofuscinosisAndrew M S Wong, Ahad A Rahim, Simon N Waddington, et al.
Brain Pathology (Zurich, Switzerland)|December 21, 2004
Hippocampal pathology in the human neuronal ceroid-lipofuscinoses: distinct patterns of storage deposition, neurodegeneration and glial activationJaana Tyynelä, Jonathan D Cooper, M Nadeem Khan, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|November 4, 2019
Pathomechanisms in the neuronal ceroid lipofuscinosesHemanth R Nelvagal, Jenny Lange, Keigo Takahashi, et al.
Brain : a Journal of Neurology|April 17, 2013
A zebrafish model of CLN2 disease is deficient in tripeptidyl peptidase 1 and displays progressive neurodegeneration accompanied by a reduction in proliferationFahad Mahmood, Sonia Fu, Jennifer Cooke, et al.
Pageof 15

Showing results (21-30 of 144) with videos related to

Sort By:
Pageof 15
Neurobiology of Disease|July 12, 2005
Thalamocortical neuron loss and localized astrocytosis in the Cln3Deltaex7/8 knock-in mouse model of Batten diseaseCharlie C Pontikis, Susan L Cotman, Marcy E MacDonald, et al.
Neurobiology of Disease|May 10, 2012
Selective spatiotemporal patterns of glial activation and neuron loss in the sensory thalamocortical pathways of neuronal ceroid lipofuscinosis 8 miceMervi Kuronen, Anna-Elina Lehesjoki, Anu Jalanko, et al.
Journal of Child Neurology|September 10, 2013
Regional brain atrophy in mouse models of neuronal ceroid lipofuscinosis: a new rostrocaudal perspectiveThomas G Kühl, Sybille Dihanich, Andrew M S Wong, et al.
Acta Neuropathologica|October 10, 2007
Immune system irregularities in lysosomal storage disordersJulian A Castaneda, Ming J Lim, Jonathan D Cooper, et al.
Journal of Neuropathology and Experimental Neurology|December 14, 2011
Early microglial activation precedes neuronal loss in the brain of the Cstb-/- mouse model of progressive myoclonus epilepsy, EPM1Saara Tegelberg, Outi Kopra, Tarja Joensuu, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 13, 2025
Immunostaining Methods for Lysosomal Storage Disorder ResearchEwa A Ziółkowska, Sophie H Wang, Hemanth R Nelvagal, et al.
Biochemical Society Transactions|December 2, 2010
Current therapies for the soluble lysosomal forms of neuronal ceroid lipofuscinosisAndrew M S Wong, Ahad A Rahim, Simon N Waddington, et al.
Brain Pathology (Zurich, Switzerland)|December 21, 2004
Hippocampal pathology in the human neuronal ceroid-lipofuscinoses: distinct patterns of storage deposition, neurodegeneration and glial activationJaana Tyynelä, Jonathan D Cooper, M Nadeem Khan, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|November 4, 2019
Pathomechanisms in the neuronal ceroid lipofuscinosesHemanth R Nelvagal, Jenny Lange, Keigo Takahashi, et al.
Brain : a Journal of Neurology|April 17, 2013
A zebrafish model of CLN2 disease is deficient in tripeptidyl peptidase 1 and displays progressive neurodegeneration accompanied by a reduction in proliferationFahad Mahmood, Sonia Fu, Jennifer Cooke, et al.
Pageof 15